American journal of surgery · 2026
Experiences and challenges of sexual and gender minority patients undergoing breast cancer treatment.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Barmettler Gabi, Kohlbeck Sara, Cortina Chandler S, Kantor Olga
Аннотация
BACKGROUND: This survey study sought to characterize the experiences and treatments of sexual and gender minority (SGM) patients with breast cancer.
METHODS: The WhySurg survey was modified to focus on SGM patients and distributed via social media, support groups, and clinic flyers between 2023 and 2024. SGM individuals, age ≥18, and a history of breast cancer were eligible. Descriptive and reflexive thematic analyses were performed.
RESULTS: 50 individuals responded, with 31 (62%) completing it. Most (77%) were cisgender women, 16% nonbinary, and 3% transgender man. Most (58%) were lesbian/gay/homosexual, while 23% were bisexual, 13% pansexual, 13% queer, 3% asexual, 1 heterosexual, and 1 other. 29% experienced discrimination related to their SGM identity during treatment. Three themes emerged: 1) SGM identity influenced surgical choice, 2) respondents were reluctant to share SGM identity, and 3) appropriate surgical expectations are key to optimize gender-affirming patient-centered outcomes.
CONCLUSION: SGM data is essential to ensure patient-centered surgical decision-making.
METHODS: The WhySurg survey was modified to focus on SGM patients and distributed via social media, support groups, and clinic flyers between 2023 and 2024. SGM individuals, age ≥18, and a history of breast cancer were eligible. Descriptive and reflexive thematic analyses were performed.
RESULTS: 50 individuals responded, with 31 (62%) completing it. Most (77%) were cisgender women, 16% nonbinary, and 3% transgender man. Most (58%) were lesbian/gay/homosexual, while 23% were bisexual, 13% pansexual, 13% queer, 3% asexual, 1 heterosexual, and 1 other. 29% experienced discrimination related to their SGM identity during treatment. Three themes emerged: 1) SGM identity influenced surgical choice, 2) respondents were reluctant to share SGM identity, and 3) appropriate surgical expectations are key to optimize gender-affirming patient-centered outcomes.
CONCLUSION: SGM data is essential to ensure patient-centered surgical decision-making.